Skip to main content

Advertisement

SpringerLink
Log in

Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Musculoskeletal symptoms are the most frequent extra-intestinal manifestations of inflammatory bowel disease (IBD), ranging between 10 and 40 % of cases. Pathogenesis is still unclear, although several factors have been associated (genetic, environmental, and immunologic pathways). Rheumatic manifestations in IBD patients are heterogeneous, including axial and peripheral involvement, dactylitis, enthesitis, uveitis, as well as skin involvement. Currently, magnetic resonance imaging and ultrasonography are important tools for detecting early pathological changes in IBD patients with suspected rheumatic disease. New advances into the genetics and pathophysiology have provided more effective and targeted therapy for IBD patients with rheumatic manifestations. Given the high prevalence, awareness of the musculoskeletal symptoms is essential to avoid a misdiagnosis. Finally, an interdisciplinary approach of IBD patients, including rheumatologist and gastroenterologist, will improve the quality of life these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bourikas LA, Papadakis KA (2009) Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 15:1915–24

    Article  PubMed  Google Scholar 

  2. Cosnes J, Gower-Rousseau C, Seksik P et al (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140(6):1785–1794

    Article  PubMed  Google Scholar 

  3. Das KM (1999) Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 44:1–13

    Article  CAS  PubMed  Google Scholar 

  4. Levine JS, Burakoff R (2011) Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (NY) 7:235–241

    Google Scholar 

  5. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429

    Article  CAS  PubMed  Google Scholar 

  6. Arvikar SL, Fisher MC (2011) Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med 4:123–131

    Article  PubMed Central  PubMed  Google Scholar 

  7. Salvarani C, Vlachonikolis IG, van der Heijde D et al (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–13

    Article  CAS  PubMed  Google Scholar 

  8. Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel diseases. Autoimmun Rev 13:20–23

    Article  PubMed  Google Scholar 

  9. Trikudanathan G, Venkatesh PG, Navaneethan U (2012) Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs 72:2333–2349

    Article  CAS  PubMed  Google Scholar 

  10. Jewell D (2008) Do HLA antigens predict the occurrence of extraintestinal manifestations of IBD? Inflamm Bowel Dis 14(suppl 2):S28

    Article  PubMed  Google Scholar 

  11. Mielants H, Veys EM (1990) The gut in the spondyloarthropathies. J Rheumatol 17:7–10

    CAS  PubMed  Google Scholar 

  12. van Sommeren S, Janse M, Karjalainen J et al (2014) Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways. Inflamm Bowel Dis 20:987–994

    PubMed  Google Scholar 

  13. Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. van Praet L, van den Bosch F, Mielants H et al (2011) Mucosal inflammation in spondylarthritides: past, present, and future. Curr Rheumatol Rep 13:409–415

    Article  PubMed  Google Scholar 

  15. Costello ME, Robinson P, Benham H et al (2015) The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis. Best Pract Res Clin Rheumatol 29(2):202–212

    Article  PubMed  Google Scholar 

  16. Scher JU, Ubeda C, Artacho A et al (2015) Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 67(1):128–39

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–98

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Brandtzaeg P (1997) Review article: homing of mucosal immune cells—a possible connection between intestinal and articular inflammation. Aliment Pharmacol Ther 11(suppl 3):24–37, discussion 37–29

    PubMed  Google Scholar 

  19. Baeten D, De Keyser F, Mielants H et al (2002) Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 14:342–347

    Article  PubMed  Google Scholar 

  20. Mueller C (2012) Danger-associated molecular patterns and inflammatory bowel disease: is there a connection? Dig Dis 30(suppl 3):40–46

    Article  PubMed  Google Scholar 

  21. Sheth T, Pitchumoni C, Das K (2014) Musculoskeletal manifestations in inflammatory bowel diseases. J Clin Gastroenterol 48:308–317

    Article  PubMed  Google Scholar 

  22. Cho JH, Brant SR (2011) Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140:1704–1712

    Article  CAS  PubMed  Google Scholar 

  23. Abraham C, Cho JH (2006) Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 12:641–650

    Article  PubMed  Google Scholar 

  24. Lees CW, Barrett JC, Parkes M et al (2011) New IBD genetics: common pathways with other diseases. Gut 60:1739–1753

    Article  CAS  PubMed  Google Scholar 

  25. De Vos M, Hindryckx P, Laukens D (2011) Novel development in extraintestinal manifestations and spondylarthropathy. Best Pract Res Clin Gastroenterol 25(suppl 1):S19–S26

    Article  PubMed  Google Scholar 

  26. Sandborn WJ, Gasink C, Gao LL et al (2012) Ustekinumab induction and maintenance therapy in refractory Crohn’s disease. N Engl J Med 367:1519–1528

    Article  CAS  PubMed  Google Scholar 

  27. Calin A, Porta J, Fries JF et al (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237:2613–4

    Article  CAS  PubMed  Google Scholar 

  28. Salvarani C, Fries W (2009) Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol 15(20):2449–2455

    Article  PubMed Central  PubMed  Google Scholar 

  29. Palm O, Moum B, Ongre A et al (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 29:511–5

    PubMed  Google Scholar 

  30. Scarpa R, del Puente A, D’Arienzo A et al (1992) The arthritis of ulcerative colitis: clinical and genetic aspects. J Rheumatol 19:373–7

    CAS  PubMed  Google Scholar 

  31. Dekker-Saeys BJ, Meuwissen SG, Van Den Berg-Loonen EM et al (1978) Ankylosing spondylitis and inflammatory bowel disease. Clinical characteristics and results of histocompatibility typing (HLA-B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann Rheum Dis 37:36–41

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–91

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Lanna CC, Ferrari M de L, Rocha SL et al (2008) A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol 27:503–9

  34. Queiro R, Maiz O, Intxausti J et al (2000) Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 19:445–9

    Article  CAS  PubMed  Google Scholar 

  35. Veloso FT, Carvalho J, Magro F (1996) Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23:29–34

    Article  CAS  PubMed  Google Scholar 

  36. de Vlam K, Mielants H, Cuvelier C et al (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–5

    PubMed  Google Scholar 

  37. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–8

    Article  PubMed  Google Scholar 

  38. Leclerc-Jacob S, Lux G et al (2014) The prevalence of inflammatory sacroiliitis assesses on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 39:957–962

    Article  CAS  PubMed  Google Scholar 

  39. Perez-Alamino R, Maldonado-Cocco JA, Citera G et al (2011) Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel diseases. J Rheumatol 38:1656–1660

    Article  PubMed  Google Scholar 

  40. Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–83

    Article  CAS  PubMed  Google Scholar 

  41. Alnaqbi K, Touma Z, Passalent L et al (2013) Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol 40:1726–1735

    Article  PubMed  Google Scholar 

  42. Palm O, Moum B, Jahnsen J et al (2001) The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 40(11):1256–1261

    Article  CAS  PubMed  Google Scholar 

  43. Rodriguez-Reyna T, Martinez-Reyes C, Yamamoto-Furusho JK (2009) Rheumatic manifestations of inflammatory bowel disease. World J Gastroenterol 15(44):5517–5524

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Yuksel I, Ataseven H, Basar O et al (2011) Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 56(1):183–187

    Article  PubMed  Google Scholar 

  45. Bandinelli F, Manetti M, Ibba-Manneschi L (2015). Occult spondyloarthritis in inflammatory bowel disease. Clin Rheumatol

  46. Bandinelli F, Matucci-Cerinic M (2012) The role of ultrasound of entheses in spondyloarthritis—New perspectives in the diagnosis and the importance of the “occult enthesitis”. Eur Muscoloskel Rev 7:116–120

    Google Scholar 

  47. Zippi M, Corrado C, Pica R et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20(46):17463–7

    Article  PubMed Central  PubMed  Google Scholar 

  48. Greenstein A, Janowitz H, Sachar D (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55:401–412

    Article  CAS  Google Scholar 

  49. Bernstein C, Blanchard J, Rawsthorne P et al (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122

    Article  CAS  PubMed  Google Scholar 

  50. Marzano AV, Borghi A, Stadnicki A et al (2014) Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20:213–227

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Rheumatology Section, Department of Internal Medicine, Hospital Avellaneda, Tucumán, Argentina

      Rodolfo Perez-Alamino

    2. Rheumatology, Clinica del Sud. Río Cuarto, Cordoba, Argentina

      Hernan Maldonado-Ficco

    3. School of Medicine, Buenos Aires University, Buenos Aires, Argentina

      José A. Maldonado-Cocco

    Authors
    1. Rodolfo Perez-Alamino
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Hernan Maldonado-Ficco
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. José A. Maldonado-Cocco
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to José A. Maldonado-Cocco.

    Ethics declarations

    Disclosures

    None.

    Additional information

    Rodolfo Perez-Alamino and Hernan Maldonado-Ficco contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Perez-Alamino, R., Maldonado-Ficco, H. & Maldonado-Cocco, J.A. Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35, 291–296 (2016). https://doi.org/10.1007/s10067-015-3116-6

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10067-015-3116-6

    Keywords

    Search

    Navigation